Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7732
|
pubmed:dateCreated |
1972-2-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1039-40
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4108099-Anxiety Disorders,
pubmed-meshheading:4108099-Depression,
pubmed-meshheading:4108099-Humans,
pubmed-meshheading:4108099-Lysergic Acid Diethylamide,
pubmed-meshheading:4108099-Male,
pubmed-meshheading:4108099-Propranolol,
pubmed-meshheading:4108099-Psychoses, Substance-Induced
|
pubmed:year |
1971
|
pubmed:articleTitle |
Propranolol for L.S.D.-induced anxiety states.
|
pubmed:publicationType |
Journal Article
|